Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Adoptive Cell Therapy Across Cancer Diagnoses

Trial Profile

Adoptive Cell Therapy Across Cancer Diagnoses

Phase of Trial: Phase I/II

Latest Information Update: 03 Aug 2018

At a glance

  • Drugs Aldesleukin (Primary) ; Cyclophosphamide (Primary) ; Ipilimumab (Primary) ; Nivolumab (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 09 Nov 2017 Planned End Date changed from 14 Mar 2020 to 13 Mar 2020.
    • 09 Nov 2017 Planned primary completion date changed from 14 Oct 2019 to 13 Oct 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top